Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of New Era Energy & Digital, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Allegations and Impact - New Era Energy & Digital's stock fell 6.9% on December 12, 2025, following a report from Fuzzy Panda Research that accused the company of spending 2.5 times more on stock promotions than on operating its oil and gas wells [3]. - The report also highlighted the CEO E. Will Gray II's history of mismanaging penny stock companies over approximately 20 years [3]. Group 2: Legal Actions and Investor Rights - Investors who purchased New Era Energy & Digital securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses and encourages affected investors to join [2]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Points - Rosen Law Firm is reminding purchasers of CoreWeave, Inc. securities from March 28, 2025, to December 15, 2025, about the lead plaintiff deadline on March 13, 2026 [1] - Investors who purchased CoreWeave securities during the specified period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has been filed against CoreWeave, and interested parties can join by contacting Rosen Law Firm [3][6] Case Details - The lawsuit alleges that CoreWeave's defendants made false and misleading statements regarding the company's ability to meet customer demand and the risks associated with reliance on a single third-party data center supplier [5] - It is claimed that these misrepresentations were likely to have a material negative impact on CoreWeave's revenue, leading to investor damages when the truth was revealed [5] Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4] - The firm has consistently ranked highly in securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Bath & Body Works, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on March 16, 2026, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Bath & Body Works securities between June 4, 2024, and November 19, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting the law firm or visiting their website [3][6]. - To serve as lead plaintiff, individuals must file a motion with the Court by March 16, 2026, representing other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been recognized as a leader in the field of securities class action litigation [4]. Group 3: Case Allegations - The lawsuit alleges that Bath & Body Works made materially false and misleading statements regarding its business strategy and financial performance, which misled investors [5]. - Specific claims include the failure of the company's strategy to grow its customer base and the reliance on brand collaborations to mask weak financial results [5]. - As a result of these misleading statements, the company was unlikely to meet its previously issued financial guidance, leading to investor damages when the truth was revealed [5].

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Beyond Meat, Inc. (NASDAQ: BYND) between February 27, 2025 and November 11, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 24, 2026. SO WHAT: If you purchased Beyond Meat securities during the Class Perio ...

New York, New York--(Newsfile Corp. - February 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bellring Brands, Inc. (NYSE: BRBR) between November 19, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 23, 2026 lead plaintiff deadline.SO WHAT: If you purchased BellRing securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fe ...

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Varonis Systems, Inc. (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, both dates inclusive (the “Class Period”), of the important March 9, 2026 lead plaintiff deadline. SO WHAT: If you purchased Varonis common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Varonis Systems, Inc. (NASDAQ: VRNS) common stock between February 4, 2025, and October 28, 2025, of the March 9, 2026, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Varonis common stock during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by March 9, 2026 [3]. - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that Varonis made materially false and misleading statements regarding its ability to maintain Annual Recurring Revenue (ARR) projections while transitioning customers to a software-as-a-service (SaaS) model [5]. - It is claimed that Varonis was not adequately prepared to convince existing users of the benefits of the SaaS offering, leading to reduced ARR growth potential [5]. - The lawsuit asserts that the positive statements made by Varonis about its business and prospects were misleading and lacked a reasonable basis, resulting in investor damages when the truth was revealed [5].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of New Era Energy & Digital, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Allegations and Impact - New Era Energy & Digital's stock fell 6.9% on December 12, 2025, following a report from Fuzzy Panda Research that criticized the company's financial practices, claiming it spent 2.5 times more on stock promotions than on operating its oil and gas wells [3]. - The report also alleged that CEO E. Will Gray II has a history of mismanaging penny stock companies over approximately 20 years [3]. Group 2: Legal Actions and Investor Rights - Investors who purchased New Era Energy & Digital securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees or costs due to a contingency fee arrangement [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses and encourages affected investors to join the action [2]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for the number of settlements [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a leading figure in the plaintiffs' bar [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Vistagen Therapeutics, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on March 16, 2026 [1]. Group 1: Class Action Details - Investors who bought Vistagen common stock between April 1, 2024, and December 16, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][7]. - The lead plaintiff must file a motion with the Court by March 16, 2026, to represent other class members in the litigation [3]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company and has been ranked highly for its success in this area [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [4]. Group 3: Case Background - The lawsuit alleges that Vistagen provided misleading information regarding its drug fasedienol, which is under development for treating social anxiety disorder [5]. - Defendants reportedly made overly positive statements about the drug's trial success while concealing adverse facts about the Phase 3 PALISADE-3 trial [6].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Lakeland Industries, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Legal Action - Shareholders who purchased Lakeland securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to Lakeland Industries [2]. Group 2: Financial Performance and Stock Impact - On December 9, 2025, Lakeland Industries announced the withdrawal of its previously issued financial guidance for the 2026 fiscal year and stated it would not provide financial guidance going forward [3]. - Following this announcement, Lakeland's stock experienced a significant decline of 38.97% on December 10, 2025 [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [4].